Provided By GlobeNewswire
Last update: May 7, 2025
ROCHESTER, NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced it is enabling optics for the clinical development of innovative, non-incisional optics-based refractive error correction to recover near vision. This common age-related vision condition, affecting an estimated 128 million people in the U.S. alone, presents a significant and growing market opportunity for effective treatment solutions.
Read more at globenewswire.comNASDAQ:OPTX (8/29/2025, 8:00:02 PM)
1.6
-0.02 (-1.23%)
Find more stocks in the Stock Screener